Long noncoding RNA CDKN2B‐AS1 silencing protects against esophageal cancer cell invasion and migration by inactivating the TFAP2A/FSCN1 axis

Long noncoding RNA CDKN2B‐AS1 silencing protects against esophageal cancer cell invasion and migration by inactivating the TFAP2A/FSCN1 axis

Abstract Esophageal cancer (EC) is the most aggressive malignancy in the gastrointestinal tract. Long noncoding RNA cyclin‐dependent kinase inhibitor 2 B antisense RNA 1 (CDKN2B‐AS1) is implicated in EC development. However, the specific mechanisms involved remain poorly defined. Therefore, this res...

Full description

Bibliographic Details
Main Authors:	Jia‐Liang Zhu, Wen‐Bo Xue, Zhi‐Bin Jiang, Wei Feng, Yi‐Cai Liu, Xiong‐Ying Nie, Long‐Yu Jin
Format:	Article
Language:	English
Published:	Wiley 2022-12-01
Series:	Kaohsiung Journal of Medical Sciences
Subjects:	esophageal cancer fascin actin‐bundling protein 1 long noncoding RNA CDKN2B‐AS1 malignant behaviors transcription factor AP‐2 alpha
Online Access:	https://doi.org/10.1002/kjm2.12596

Similar Items

A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation
by: Selena G. Burgess, et al.
Published: (2024-03-01)

Cooperative bundling by fascin generates actin structures with architectures that depend on filament length
by: Laura A. Sherer, et al.
Published: (2022-09-01)

Structural Analysis of Human Fascin-1: Essential Protein for Actin Filaments Bundling
by: Jeong Min Chung, et al.
Published: (2022-06-01)

ADORA2A-AS1 Restricts Hepatocellular Carcinoma Progression via Binding HuR and Repressing FSCN1/AKT Axis
by: Jian Pu, et al.
Published: (2021-10-01)

ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease
by: Yahui Kong, et al.
Published: (2018-07-01)

Ezh2 Regulates Activation-Induced CD8+ T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression
by: Guobing Chen, et al.
Published: (2018-03-01)

LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2
by: Mengjun Guo, et al.
Published: (2022-03-01)

Deoxyribonucleic acid methylation in the enhancer region of the CDKN2A/2B and CDKN2B-AS1 genes in blood vessels and cells in patients with carotid atherosclerosis
by: Yu. A. Koroleva, et al.
Published: (2020-11-01)

Expression of cyclin-dependent kinase inhibitors (CDKN1, CDKN5) in developmentally competent and incompetent porcine oocytes
by: H. Piotrowska, et al.
Published: (2013-09-01)

Recapitulating Actin Module Organization in the <i>Drosophila</i> Oocyte Reveals New Roles for Bristle-Actin-Modulating Proteins
by: Ramesh Kumar Krishnan, et al.
Published: (2021-04-01)

Actin Bundles Dynamics and Architecture
by: Sudeepa Rajan, et al.
Published: (2023-02-01)

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer
by: Giulia Cantini, et al.
Published: (2021-06-01)

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia
by: E. Genescà, et al.
Published: (2018-07-01)

Genetic alterations of CDX1, CYLD and CDKN2B genes in CRC
by: Seyed Mohammad Taghi Hamidian, et al.
Published: (2021-09-01)

DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2
by: Yifan Lian, et al.
Published: (2018-10-01)

Stimulation of c-Jun/AP-1-Activity by the Cell Cycle Inhibitor p57Kip2
by: Michael Keith Kullmann, et al.
Published: (2021-04-01)

CDKN2B-AS1 gene rs4977574 polymorphism in the severity of coronary artery disease in the Kazakh population
by: Askhat Myngbay, et al.
Published: (2023-12-01)

Negative regulation of CDKN1A by the histone methyltransferase EHMT2 for cell growth in colorectal cancer
by: Kwangho Kim, et al.
Published: (2022-09-01)

Aberrant methylation of CDKN2A, RASSF1A and WIF1 in sporadic adenocarcinomatous colorectal cancer: Associations with clinicopathological features
by: Linh Dieu Vuong, et al.
Published: (2021-12-01)

Retracted: Interference of the long noncoding RNA CDKN2B‐AS1 upregulates miR‐181a‐5p/TGFβI axis to restrain the metastasis and promote apoptosis and senescence of cervical cancer cells
by: Lihong Zhu, et al.
Published: (2019-04-01)

MAF1 represses CDKN1A through a Pol III-dependent mechanism
by: Yu-Ling Lee, et al.
Published: (2015-06-01)

Corrigendum: Fragile Gene WWOX Guides TFAP2A/TFAP2C-Dependent Actions Against Tumor Progression in Grade II Bladder Cancer
by: Damian Kołat, et al.
Published: (2021-08-01)

Investigation of MLH1, MGMT, CDKN2A, and RASSF1A Gene Methylation in Thymomas From Patients With Myasthenia Gravis
by: Fabio Coppedè, et al.
Published: (2020-10-01)

Identification and targeting of a HES1‐YAP1‐CDKN1C functional interaction in fusion‐negative rhabdomyosarcoma
by: Alexander R. Kovach, et al.
Published: (2022-10-01)

Effects of CDKN2B‐AS1 polymorphisms on the susceptibility to coronary heart disease
by: Kang Huang, et al.
Published: (2019-11-01)

Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer
by: E.M. Lima, et al.
Published: (2008-06-01)

SOCS1 Deficiency Promotes Hepatocellular Carcinoma via SOCS3-Dependent CDKN1A Induction and NRF2 Activation
by: Md Gulam Musawwir Khan, et al.
Published: (2023-01-01)

Structural and Biochemical Characterization of EFhd1/Swiprosin-2, an Actin-Binding Protein in Mitochondria
by: Sang A. Mun, et al.
Published: (2021-01-01)

CDKN2AIP-induced cell senescence and apoptosis of testicular seminoma are associated with CARM1 and eIF4β
by: Cao Yuming, et al.
Published: (2022-05-01)

Polymorphism rs2383207 of CDKN2B-AS and Susceptibility to Atherosclerosis: A Mini Review
by: Sofia Vladimorovna Timofeeva, et al.
Published: (2022-11-01)

Association of Myocardial Infarction with CDKN2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 Polymorphism in Slovenian Subjects with Type 2 Diabetes Mellitus
by: Miha Tibaut, et al.
Published: (2022-03-01)

Association Between CDKAL1, HHEX, CDKN2A/2B and IGF2BP2 Gene Polymorphisms and Susceptibility to Type 2 Diabetes in Uttarakhand, India
by: Verma AK, et al.
Published: (2021-01-01)

Exosomes released from M2 macrophages transfer miR‐221‐3p contributed to EOC progression through targeting CDKN1B
by: Xiaoduan Li, et al.
Published: (2020-08-01)

LncRNA NEAT1 suppresses cellular senescence in hepatocellular carcinoma via KIF11‐dependent repression of CDKN2A
by: Danlei Chen, et al.
Published: (2023-09-01)

CDKN2A-Inactivated Pancreatic Ductal Adenocarcinoma Exhibits Therapeutic Sensitivity to Paclitaxel: A Bioinformatics Study
by: Jiunn-Chang Lin, et al.
Published: (2020-12-01)

Molecular Genetics and Functional Analysis Implicate <i>CDKN2BAS1-CDKN2B</i> Involvement in POAG Pathogenesis
by: Sonika Rathi, et al.
Published: (2020-08-01)

Silencing of microRNA-517a induces oxidative stress injury in melanoma cells via inactivation of the JNK signaling pathway by upregulating CDKN1C
by: Chao Yang, et al.
Published: (2020-01-01)

High expression of CDKN2A is associated with poor prognosis in colorectal cancer and may guide PD-1-mediated immunotherapy
by: Yuying Dong, et al.
Published: (2023-11-01)

CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune Microenvironment
by: Di Yang, et al.
Published: (2021-10-01)

CDKN2BAS gene polymorphisms and the risk of intracranial aneurysm in the Chinese population
by: Yunchang Chen, et al.
Published: (2017-12-01)